Avidity Biosciences
Avidity Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in RNA therapeutics. The company utilizes its proprietary Antibody Oligonucleotide Conjugates (AOCs™) platform to develop targeted therapies for rare diseases, with a particular focus on neuromuscular disorders. Avidity aims to revolutionize RNA therapeutics by combining the specificity of monoclonal antibodies with the precision of oligonucleotides, enabling effective treatment of previously untreatable conditions. Avidity's clinical-stage pipeline includes programs targeting Myotonic Dystrophy Type 1, Facioscapulohumeral Muscular Dystrophy, and Duchenne Muscular Dystrophy. The company is also exploring opportunities in precision cardiology and immunology. With a team of approximately 391 employees, Avidity is committed to innovation in the field of rare diseases, collaborating with healthcare providers and academic institutions to enhance patient outcomes.
Work at Avidity Biosciences in HR or recruiting? Claim this page
Headcount trend
Avidity Biosciences went from 196 employees in Jun 2023 to 403 in May 2025. Dec 2024 to May 2025: 78 people joined, 2 left.
Headcount data through May 2025
Org structure
Headcount by department
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 2 filings.
Peer reviews
Worked with someone at Avidity Biosciences?
Anonymous peer reviews on OffTheRecord
Similar companies
Avidity Biosciences FAQ
How many employees does Avidity Biosciences have?
Avidity Biosciences has about 403 employees, up 4.9% over the 3 months to May 2025.
Does Avidity Biosciences sponsor H1B visas?
Yes. Avidity Biosciences filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Avidity Biosciences's revenue per employee?
Avidity Biosciences makes about $22K in revenue per employee, based on $8.92M annual revenue and 403 employees.
Is Avidity Biosciences a public company?
Yes. Avidity Biosciences is publicly traded under the ticker RNA on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.
